2022
DOI: 10.1093/ajh/hpac011
|View full text |Cite
|
Sign up to set email alerts
|

Blood Pressure Control Among Non-Hispanic Black Adults Is Lower Than Non-Hispanic White Adults Despite Similar Treatment With Antihypertensive Medication: NHANES 2013–2018

Abstract: Background Controlled blood pressure can prevent or reduce adverse health outcomes. Social and structural determinants may contribute to the disparity that despite equivalent proportions on anti-hypertensive medication, non-Hispanic Black (Black) adults have lower blood pressure control and more cardiovascular events than non-Hispanic White (White) adults. Methods Data from 2013-2018 National Health and Nutrition Examination … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 11 publications
(2 citation statements)
references
References 35 publications
0
2
0
Order By: Relevance
“… 34 Even among those taking antihypertensive medications by medication class, differences in the proportion of adults with controlled hypertension have been observed by race/ethnicity and SES. 35 This suggests that some patients with hypertension need additional support for healthcare and lifestyle management, which has implications for cardiovascular disease risk. For example, among a national, population-based sample (age ≥45 years) without coronary heart disease at baseline, greater SDOH burdens were associated with fatal incident coronary heart disease than among those without SDOH burdens.…”
Section: Discussionmentioning
confidence: 99%
“… 34 Even among those taking antihypertensive medications by medication class, differences in the proportion of adults with controlled hypertension have been observed by race/ethnicity and SES. 35 This suggests that some patients with hypertension need additional support for healthcare and lifestyle management, which has implications for cardiovascular disease risk. For example, among a national, population-based sample (age ≥45 years) without coronary heart disease at baseline, greater SDOH burdens were associated with fatal incident coronary heart disease than among those without SDOH burdens.…”
Section: Discussionmentioning
confidence: 99%
“… 24 We graded the intensity of BP-lowering medication according to the number of BP-lowering medication classes used simultaneously, in accordance with the International Society of Hypertension guidelines 7 and as done in previous studies. 25 , 26 In sensitivity analyses, we graded intensity of medication using the number of antihypertensive pills to take into account polypharmacy burden as well as the fact that some classes can be combined in a single pill. 27 Finally, we assessed medication intensity using the Therapeutic Intensity Score (TIS).…”
Section: Methodsmentioning
confidence: 99%